Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Share-based Compensation (2016 - 2025)

Ptc Therapeutics has reported Share-based Compensation over the past 14 years, most recently at $18.5 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $18.5 million for Q4 2025, up 7.42% from a year ago — trailing twelve months through Dec 2025 was $74.5 million (changed 0.09% YoY), and the annual figure for FY2025 was $74.5 million, changed 0.09%.
  • Share-based Compensation for Q4 2025 was $18.5 million at Ptc Therapeutics, down from $19.4 million in the prior quarter.
  • Over the last five years, Share-based Compensation for PTCT hit a ceiling of $29.4 million in Q2 2023 and a floor of $17.2 million in Q4 2024.
  • Median Share-based Compensation over the past 5 years was $25.7 million (2021), compared with a mean of $23.6 million.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 68.9% in 2021 and later plummeted 36.22% in 2024.
  • Ptc Therapeutics' Share-based Compensation stood at $26.2 million in 2021, then grew by 4.22% to $27.3 million in 2022, then fell by 1.47% to $26.9 million in 2023, then crashed by 36.01% to $17.2 million in 2024, then grew by 7.42% to $18.5 million in 2025.
  • The last three reported values for Share-based Compensation were $18.5 million (Q4 2025), $19.4 million (Q3 2025), and $18.5 million (Q2 2025) per Business Quant data.